Validation Study of Pyrroloquinoline quinone disodium salt (PQQ 2Na) for Improvement of Brain Function in Healthy Adults
Not Applicable
- Conditions
- Healthy subjects
- Registration Number
- JPRN-UMIN000034459
- Lead Sponsor
- HUMA R&D CORP
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients suffering from serious liver and kidney disease, heart disease, respiratory disorders, endocrine disorders, diabetes mellitus, food allergy, drug allergy, cancer, dementia and psychiatric disorders 2)Patients allergic to gelatin 3)Patients who wish to be pregnant, lactating, or pregnant during the study period 4)Patients who have ingested PQQ 2Na within 3 months before the test 5)Patients who are deemed ineligible to participate in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cognitrax and task memory tests
- Secondary Outcome Measures
Name Time Method BDNF and Overall body composition by In body